Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis

Novel Therapeutics for the Treatment of Familial Mediterranean Fever: From Colchicine to Biologics

(2013) I Grattagliano et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Treating inflammation by blocking interleukin-1 in humans

(2013) Charles A. Dinarello et al.   SEMINARS IN IMMUNOLOGY

Efficacy and Safety of Biologic Treatments in Familial Mediterranean Fever

(2012) Akgu Ozgur et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Incomplete response to colchicine in M694V homozygote FMF patients

(2012) Merav Lidar et al.   AUTOIMMUNITY REVIEWS

Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up

(2012) Z. Birsin Özçakar et al.   CLINICAL RHEUMATOLOGY

Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure

(2011) K. Stankovic Stojanovic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature

(2011) Ulrich Meinzer et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

(2010) Nilüfer Alpay et al.   RHEUMATOLOGY INTERNATIONAL

Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy

(2009) Jae J. Chae et al.   BRITISH JOURNAL OF HAEMATOLOGY

A new set of criteria for the diagnosis of familial Mediterranean fever in childhood

(2009) Fatoş Yalçınkaya et al.   RHEUMATOLOGY

Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation

(2008) C. Moser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION